Yi Li

机构：National Medical Products Administration · ORCID：0000-0003-3298-4975

发表论文 25 篇 · 总被引 728 次 · h-index 11

代表论文

• Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice (2020 · Bioactive Materials · 被引 195)
• Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice (2020 · Acta Biomaterialia · 被引 150)
• Neuronal mitochondria-targeted therapy for Alzheimer’s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems (2020 · Drug Delivery · 被引 149)
• Cell relay-delivery improves targeting and therapeutic efficacy in tumors (2020 · Bioactive Materials · 被引 38)
• Adeno-Associated Virus Engineering and Load Strategy for Tropism Modification, Immune Evasion and Enhanced Transgene Expression (2024 · International Journal of Nanomedicine · 被引 34)
• Synergistic Effect of Rhodiola rosea and Caffeine Supplementation on the Improvement of Muscle Strength and Muscular Endurance: A Pilot Study for Rats, Resistance Exercise-Untrained and -Trained Volunteers (2023 · Nutrients · 被引 26)